167 related articles for article (PubMed ID: 25922552)
1. Serum and urine biomarkers for human renal cell carcinoma.
Pastore AL; Palleschi G; Silvestri L; Moschese D; Ricci S; Petrozza V; Carbone A; Di Carlo A
Dis Markers; 2015; 2015():251403. PubMed ID: 25922552
[TBL] [Abstract][Full Text] [Related]
2. Circulating RNA in Kidney Cancer: What We Know and What We Still Suppose.
Cinque A; Vago R; Trevisani F
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071652
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA.
Nizioł J; Bonifay V; Ossoliński K; Ossoliński T; Ossolińska A; Sunner J; Beech I; Arendowski A; Ruman T
Anal Bioanal Chem; 2018 Jun; 410(16):3859-3869. PubMed ID: 29658093
[TBL] [Abstract][Full Text] [Related]
4. Dissecting responsive phenotypes through cytokine and angiogenic factor analysis.
Rini B
Ann Oncol; 2012 Jan; 23(1):6-7. PubMed ID: 22100695
[No Abstract] [Full Text] [Related]
5. Immunoreactive low-molecular-weight epidermal growth factor in urine of patients with renal cell carcinoma.
le Coutre P; Bock S; Jakse G; Petrides PE
Urol Res; 1992; 20(4):293-6. PubMed ID: 1509636
[TBL] [Abstract][Full Text] [Related]
6. Urine metabolomics for kidney cancer detection and biomarker discovery.
Ganti S; Weiss RH
Urol Oncol; 2011; 29(5):551-7. PubMed ID: 21930086
[TBL] [Abstract][Full Text] [Related]
7. [Not Available].
Ding M; Zhou W; Chen W; Mo W; Guo X; Li Y; Ji C; Liu G; Diao W; Guo H
Clin Transl Med; 2024 Feb; 14(2):e1575. PubMed ID: 38356436
[No Abstract] [Full Text] [Related]
8. CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinoma.
Diekstra MH; Swen JJ; Boven E; Castellano D; Gelderblom H; Mathijssen RH; Rodríguez-Antona C; García-Donas J; Rini BI; Guchelaar HJ
Eur Urol; 2015 Oct; 68(4):621-9. PubMed ID: 25930089
[TBL] [Abstract][Full Text] [Related]
9. Comparative membrane proteomics: a technical advancement in the search of renal cell carcinoma biomarkers.
Raimondo F; Corbetta S; Savoia A; Chinello C; Cazzaniga M; Rocco F; Bosari S; Grasso M; Bovo G; Magni F; Pitto M
Mol Biosyst; 2015 Jun; 11(6):1708-16. PubMed ID: 25926002
[TBL] [Abstract][Full Text] [Related]
10. Imaging of renal cell carcinoma.
Sankineni S; Brown A; Cieciera M; Choyke PL; Turkbey B
Urol Oncol; 2016 Mar; 34(3):147-55. PubMed ID: 26094171
[TBL] [Abstract][Full Text] [Related]
11. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
[TBL] [Abstract][Full Text] [Related]
12. Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals.
Song W; Yeh CR; He D; Wang Y; Xie H; Pang ST; Chang LS; Li L; Yeh S
Oncotarget; 2015 Aug; 6(22):19290-304. PubMed ID: 26079540
[TBL] [Abstract][Full Text] [Related]
13. Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron.
Büttner F; Winter S; Rausch S; Reustle A; Kruck S; Junker K; Stenzl A; Agaimy A; Hartmann A; Bedke J; Schwab M; Schaeffeler E
Eur Urol; 2015 Dec; 68(6):1016-20. PubMed ID: 26072688
[TBL] [Abstract][Full Text] [Related]
14. Papillary renal cell carcinoma: A review of the current therapeutic landscape.
Courthod G; Tucci M; Di Maio M; Scagliotti GV
Crit Rev Oncol Hematol; 2015 Oct; 96(1):100-12. PubMed ID: 26052049
[TBL] [Abstract][Full Text] [Related]
15. MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis.
Xiao H; Zeng J; Li H; Chen K; Yu G; Hu J; Tang K; Zhou H; Huang Q; Li A; Li Y; Ye Z; Wang J; Xu H
Oncotarget; 2015 May; 6(15):13201-15. PubMed ID: 26036633
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of CHIP leads to increased angiogenesis via VEGF-VEGFR2 pathway and poor prognosis in human renal cell carcinoma.
Sun C; Li HL; Chen HR; Shi ML; Liu QH; Pan ZQ; Bai J; Zheng JN
Sci Rep; 2015 May; 5():9774. PubMed ID: 26021863
[TBL] [Abstract][Full Text] [Related]
17. The Impact of PBRM1 Expression as a Prognostic and Predictive Marker in Metastatic Renal Cell Carcinoma.
Kim JY; Lee SH; Moon KC; Kwak C; Kim HH; Keam B; Kim TM; Heo DS
J Urol; 2015 Oct; 194(4):1112-9. PubMed ID: 25997916
[TBL] [Abstract][Full Text] [Related]
18. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
Peng H; Wang X; Zhang P; Sun T; Ren X; Xia Z
Int J Clin Exp Pathol; 2015; 8(2):2259-66. PubMed ID: 25973137
[TBL] [Abstract][Full Text] [Related]
19. Expression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma.
Chang Y; Xu L; An H; Fu Q; Chen L; Lin Z; Xu J
Int J Clin Exp Pathol; 2015; 8(2):1594-603. PubMed ID: 25973044
[TBL] [Abstract][Full Text] [Related]
20. let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.
Peng J; Mo R; Ma J; Fan J
World J Surg Oncol; 2015 May; 13():175. PubMed ID: 25951903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]